Breaking News, Collaborations & Alliances

BioMed X, Novo Nordisk Launch Oral Peptide Drug Delivery Collaboration

The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists.

By: Rachel Klemovitch

Assistant Editor

BioMed X, an independent biomedical research institute based in Heidelberg, Germany, launched a new collaboration with Novo Nordisk, a global healthcare company headquartered in Denmark.  This partnership aims to address an efficient oral delivery of therapeutic peptides. A research team will be formed to work on this challenge with support from BioMed X and Novo Nordisk. Despite advances in biomedical research, conventional oral peptide formulations continue to be limited by low intestina...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters